Childhood hypo-adiponectinaemia but not hyper-leptinaemia is associated with insulin insensitivity 6 years later

Pediatric Diabetes

Volumn 11, Issue 3, 2010, Pages 195-202

  Kynde, Iben ^a,b   Heitmann, Berit Lilienthal ^b,c   Bygbjerg, Ib Christian ^a   Andersen, Lars Bo ^c,d   Helge, Jørn Wulff ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b The Capital Region   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

Author keywords

Adipokines; Children; Inflammation; Insulin insensitivity; Overweight

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; INTERLEUKIN 8; LEPTIN; SCATTER FACTOR; GLUCOSE BLOOD LEVEL; HGF PROTEIN, HUMAN;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ACCELEROMETRY; ARTICLE; BODY MASS; CHILD; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLEPTINEMIA; HYPOADIPONECTINEMIA; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; ADOLESCENT; ANALYSIS; BLOOD; BODY WEIGHT; DOWN REGULATION; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ADIPONECTIN; ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IDEAL BODY WEIGHT; INSULIN RESISTANCE; INTERLEUKIN-8; LEPTIN; MALE; OVERWEIGHT; TIME FACTORS;

EID: 77954454149     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00556.x     Document Type: Article

References (36)

1. Jackson-Leach R, Lobstein T. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 1. The increase in the prevalence of child obesity in Europe is itself increasing. Int J Pediatr Obes 2006, 1:26-32.
2. Molnar D. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. Int J Obes Relat Metab Disord 2004, 28(Suppl. 3):S70-S74.
3. Valle M, Gascon F, Martos R, Bermudo F, Ceballos P, Suanes A. Relationship between high plasma leptin concentrations and metabolic syndrome in obese pre-pubertal children. Int J Obes Relat Metab Disord 2003, 27:13-18.
4. Slinger JD, Van BE, Keizer H, Rump P, Hornstra G, Kuipers H. Insulin resistance, physical fitness, body composition and leptin concentration in 7-8 year-old children. J Sci Med Sport 2008, 11:132-138.
5. Tsou PL, Jiang YD, Chang CC. Sex-related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care 2004, 27:308-313.
6. Schmidt MI, Duncan BB, Vigo A. Leptin and incident type 2 diabetes: risk or protection? Diabetologia 2006, 49:2086-2096.
7. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919.
8. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006, 74:443-477.
9. Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 2003, 148:535-542.
10. Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B. Serum interleukin-8 level is increased in diabetic patients. Diabetologia 1999, 42:117-118.
11. Bottner A, Kratzsch J, Muller G. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004, 89:4053-4061.
12. Roemmich JN, Clark PA, Berr SS. Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids. Am J Physiol 1998, 275:E543-E551.
13. Rehman J, Considine RV, Bovenkerk JE. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 2003, 41:1408-1413.
14. Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006, 188:231-244.
15. Riddoch CJ, Edward D, Page AS. The European Youth Heart Study -cardiovascular disease risk factors in children: rationale, aims, study design and validation of methods. J Phys Act Health 2005, 2:115-129.
16. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976, 51:170-179.
17. Kristensen PL, Moller NC, Korsholm L, Wedderkopp N, Andersen LB, Froberg K. Tracking of objectively measured physical activity from childhood to adolescence: the European Youth Heart Study. Scand J Med Sci Sports 2008, 18:171-178.
18. Janz KF. Validation of the CSA accelerometer for assessing children's physical activity. Med Sci Sports Exerc 1994, 26:369-375.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004, 27:314-319.
21. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002, 87:4652-4656.
22. Ferris WF, Naran NH, Crowther NJ, Rheeder P, Van-Der Merwe L, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 2005, 37:695-701.
23. Moran A, Jacobs DR, Steinberger J. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999, 48:2039-2044.
24. Singhal A, Jamieson N, Fewtrell M, Deanfield J, Lucas A, Sattar N. Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents. J Clin Endocrinol Metab 2005, 90:4615-4621.
25. Kantartzis K, Fritsche A, Tschritter O. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obes Res 2005, 13:1683-1691.
26. Cote M, Mauriege P, Bergeron J. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 2005, 90:1434-1439.
27. Kantartzis K, Rittig K, Balletshofer B. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 2006, 52:1934-1942.
28. Yamauchi T, Kamon J, Minokoshi Y. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295.
29. Weiss R, Taksali SE, Dufour S. The 'obese insulin-sensitive' adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab 2005, 90:3731-3737.
30. Martin LJ, Woo JG, Daniels SR, Goodman E, Dolan LM. The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity. J Clin Endocrinol Metab 2005, 90:4255-4259.
31. Aygun AD, Gungor S, Ustundag B, Gurgoze MK, Sen Y. Proinflammatory cytokines and leptin are increased in serum of prepubertal obese children. Mediators Inflamm 2005, 2005:180-183.
32. Weiss R, Dufour S, Groszmann A. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003, 88:2014-2018.
33. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
34. Dela F. On the influence of physical training on glucose homeostasis. Acta Physiol Scand Suppl 1996, 635:1-41.
35. Ring-Dimitriou S, Paulweber B, Von-Duvillard SP. The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome. Eur J Appl Physiol 2006, 98:472-481.
36. Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 2006, 42:105-117.